You’re studying the net version of D.C. Analysis, STAT’s twice-weekly publication in regards to the politics and coverage of well being and medication. Join right here to obtain it in your inbox on Tuesdays and Thursdays.
I used to be reminded lately of why I dig mass transit upon overhearing the prepare conductor and two middle-aged males engaged in a critical discuss mattresses, “trash” 400-thread-counts, and the professionals and cons of weighted sheets. Ship me your recommendations for an opulent evening’s sleep, and information tricks to [email protected] or John_Wilkerson.07 on Sign.
It’s who you understand that issues
Sarepta Therapeutics, which has come beneath regulatory stress over its gene remedy for Duchenne muscular dystrophy, employed the Trump-connected lobbying agency Michael Finest Methods after the dying of a teenage boy handled with the drug, based on lobbying disclosure stories.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
